Miltenyi Biotec GmbH-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Miltenyi Biotec GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014022
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Miltenyi Biotec GmbH (Miltenyi) is a biotechnology company which provides biomedical research and cellular therapy products for cell isolation, flow cytometry, sample preparation and cell culture. The company’s services include sample preparation, cell separation, flow cytometry, cell culture and stimulation, molecular, clinical applications and viscover imaging. It also offers cytometers, analyzers, reagents, buffers, imaging instruments, and software solutions. Miltenyi conducts research in the areas of oncology, cardiovascular disease, metabolic disorders, immunology, neurology and infection. The company has presence in Germany, the US, the UK, France, Italy, Singapore, Japan, South Korea, and others. Miltenyi is headquartered in Bergisch Gladbach, North Rhine-Westphalia, Germany.

Miltenyi Biotec GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Miltenyi Biotec GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Miltenyi Biotec GmbH, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Miltenyi Biotec GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Miltenyi Biotec GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Miltenyi Biotec GmbH, Medical Devices Deals, 2011 to YTD 2017 9
Miltenyi Biotec GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Miltenyi Biotec GmbH, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Miltenyi Biotec Acquires Gene Therapy Assets from Lentigen 11
Venture Financing 12
Owl Biomedical Raises US$3 Million In Series A Financing 12
Partnerships 13
GlaxoSmithKline Enters into Agreement with Miltenyi Biotec 13
Cesca Therapeutics Enters into Distribution Agreement with Miltenyi Biotec 14
Applied Microarrays Enters Into Co-Development Agreement With Sensovation For FlexiPlex Array System 15
Miltenyi Biotec Enters Into Co-Development Agreement With TeutoCell For Novel Cell Culture Media 16
Licensing Agreements 17
Living Pharma Enters into Licensing Agreement with University of Maryland, Baltimore 17
Miltenyi Biotec Enters into Licensing Agreement with Genethon 18
Accellta Enters into Licensing Agreement with Miltenyi Biotec 19
Nanolek To Enter Into Licensing Agreement With Lentigen For Flu Vaccine 20
Asset Transactions 21
Miltenyi Biotec Acquires Gene Therapy Assets from Lentigen 21
Acquisition 22
Lentigen Technology Acquires Living Pharma 22
Miltenyi Biotec Acquires Sensovation 23
Miltenyi Biotec Acquires Owl Biomedical, Disposable Cell Sorting Technology Provider 24
Miltenyi Biotec GmbH – Key Competitors 25
Miltenyi Biotec GmbH – Key Employees 26
Miltenyi Biotec GmbH – Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Recent Developments 29
Legal and Regulatory 29
Sep 19, 2016: CE marked MACS IVD Antibodies by Miltenyi Biotec – Compliant with IVDD and produced according to ISO 13485 29
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
Miltenyi Biotec GmbH, Pharmaceuticals & Healthcare, Key Facts 2
Miltenyi Biotec GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Miltenyi Biotec GmbH, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Miltenyi Biotec GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Miltenyi Biotec GmbH, Deals By Therapy Area, 2011 to YTD 2017 8
Miltenyi Biotec GmbH, Medical Devices Deals, 2011 to YTD 2017 9
Miltenyi Biotec GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Miltenyi Biotec Acquires Gene Therapy Assets from Lentigen 11
Owl Biomedical Raises US$3 Million In Series A Financing 12
GlaxoSmithKline Enters into Agreement with Miltenyi Biotec 13
Cesca Therapeutics Enters into Distribution Agreement with Miltenyi Biotec 14
Applied Microarrays Enters Into Co-Development Agreement With Sensovation For FlexiPlex Array System 15
Miltenyi Biotec Enters Into Co-Development Agreement With TeutoCell For Novel Cell Culture Media 16
Living Pharma Enters into Licensing Agreement with University of Maryland, Baltimore 17
Miltenyi Biotec Enters into Licensing Agreement with Genethon 18
Accellta Enters into Licensing Agreement with Miltenyi Biotec 19
Nanolek To Enter Into Licensing Agreement With Lentigen For Flu Vaccine 20
Miltenyi Biotec Acquires Gene Therapy Assets from Lentigen 21
Lentigen Technology Acquires Living Pharma 22
Miltenyi Biotec Acquires Sensovation 23
Miltenyi Biotec Acquires Owl Biomedical, Disposable Cell Sorting Technology Provider 24
Miltenyi Biotec GmbH, Key Competitors 25
Miltenyi Biotec GmbH, Key Employees 26
Miltenyi Biotec GmbH, Other Locations 27
Miltenyi Biotec GmbH, Subsidiaries 27

★海外企業調査レポート[Miltenyi Biotec GmbH-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • GW Pharmaceuticals Plc (GWPH):製薬・医療:M&Aディール及び事業提携情報
    Summary GW Pharmaceuticals Plc (GW Pharmaceuticals) is a biopharmaceutical company that discovers, develops and commercializes novel therapeutics from its proprietary cannabinoid product platform. The company’s commercialized product, Sativex is a plant-derived cannabinoid prescription drug, for the …
  • Celina Insurance Group:企業の戦略・SWOT・財務分析
    Celina Insurance Group - Strategy, SWOT and Corporate Finance Report Summary Celina Insurance Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Tokyo Printing Ink Mfg Co Ltd (4635)
    Tokyo Printing Ink Mfg Co Ltd (4635) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Ultra Petroleum Corp. (UPL):石油・ガス:M&Aディール及び事業提携情報
    Summary Ultra Petroleum Corp (Ultra) is an independent upstream company, which develops, produces, operates, explores, and acquires oil and natural gas properties. It develops long-life natural gas reserves in the Green River Basin of Wyoming, the Pinedale and Jonah fields, and oil reserves in the U …
  • Linn Energy, LLC:企業の戦略・SWOT・財務情報
    Linn Energy, LLC - Strategy, SWOT and Corporate Finance Report Summary Linn Energy, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Spineway SAS (ALSPW):医療機器:M&Aディール及び事業提携情報
    Summary Spineway SAS (Spineway) is a medical device company that manufactures, designs, and commercializes surgical implants and instruments. The company offers products such as thoraco-lumbar, cervical, mini invasive products and other bio materials. Its thoraco-lumbar products include mont blanc d …
  • Emcure Pharmaceuticals Ltd:企業の戦略的SWOT分析
    Emcure Pharmaceuticals Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • PromptCare Inc-医療機器分野:企業M&A・提携分析
    Summary PromptCare Inc (PromptCare) is a healthcare center that respiratory products and home infusion services. The center provides respiratory services such as clinical support programs, patient-focused technology and testimonials. It provides home infusion therapies for patients of all ages with …
  • Camden Property Trust:企業の戦略・SWOT・財務情報
    Camden Property Trust - Strategy, SWOT and Corporate Finance Report Summary Camden Property Trust - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Benihana Inc.:企業の戦略・SWOT・財務分析
    Benihana Inc. - Strategy, SWOT and Corporate Finance Report Summary Benihana Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Minoryx Therapeutics sl:製薬・医療:M&Aディール及び事業提携情報
    Summary Minoryx Therapeutics sl (Minoryx) is a clinical stage biotechnology company that develops treatments for life threatening rare diseases. The company offers discovery, preclinical research, development and clinical trial programs. It develops ALD-MIN, morquio B and PCT drugs used for lysosoma …
  • Siemens AG (SIE):石油・ガス:M&Aディール及び事業提携情報
    Summary Siemens AG (Siemens) is a technology company that offers products and solutions for electrification, automation and digitization. The company offers products, services and solutions for power generation, transmission and distribution; oil and gas production and transportation; medical imagin …
  • Wentworth Resources Ltd (WRL):石油・ガス:M&Aディール及び事業提携情報
    Summary Wentworth Resources Ltd (Wentworth) is an independent upstream oil and gas company. It conducts the exploration and development of oil and natural gas reserves. The company has producing gas assets in Tanzania, oil and gas exploration activities in both Mozambique and Tanzania. The company o …
  • Grant Thornton International Ltd:企業の戦略的SWOT分析
    Grant Thornton International Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Pacific Gas and Electric Co-石油・ガス分野:企業M&A・提携分析
    Summary Pacific Gas and Electric Company (PGEC), a subsidiary of PG&E Corporation, is an energy utility, offering electricity and natural gas to its customers. The company carries out generation, transmission and distribution of electricity. PGEC serves residential, commercial, industrial and agricu …
  • Suncor Energy Inc (SU):企業の財務・戦略的SWOT分析
    Suncor Energy Inc (SU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • PayPal Holdings Inc:企業の戦略・SWOT・財務情報
    PayPal Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary PayPal Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Yokogawa Electric Corp (6841):企業の財務・戦略的SWOT分析
    Yokogawa Electric Corp (6841) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Reata Pharmaceuticals Inc (RETA):企業の財務・戦略的SWOT分析
    Summary Reata Pharmaceuticals Inc (Reata) is a clinical-stage biopharmaceutical company that develops innovative medicines for the treatment of serious and life-threatening diseases. The company’s clinical candidates include bardoxolone methyl and omaveloxolone, which target Nrf2, a transcription fa …
  • Hogan Lovells International LLP:企業の戦略的SWOT分析
    Hogan Lovells International LLP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆